Friday, October 10, 2008

Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche

THOUSAND OAKS, Calif. – Today the United States (U.S.) Court of Appeals for the Federal Circuit issued a ruling that affirms the preliminary injunction ordered by the U.S. District Court in Boston barring Roche from selling its pegylated-erythropoietin (peg-EPO) product MIRCERA in the U.S.

Posted in Press Releases